147 related articles for article (PubMed ID: 30976660)
1. Family History of Breast Cancer Associated with Breast Cancer in Survivors of Hodgkin Lymphoma.
Colonna S; Curtin K; Johnson E; Kohlmann W; Wright J; Kirchhoff A; Tavtigian S; Schiffman J
Int J Cancer Clin Res; 2019; 6(1):. PubMed ID: 30976660
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
Krul IM; Boekel NB; Kramer I; Janus CPM; Krol ADG; Nijziel MR; Zijlstra JM; van der Maazen RWM; Roesink JM; Jacobse JN; Schaapveld M; Schmidt MK; Opstal-van Winden AWJ; Sonke GS; Russell NS; Aleman BMP; van Leeuwen FE
Cancer; 2022 Dec; 128(24):4285-4295. PubMed ID: 36281718
[TBL] [Abstract][Full Text] [Related]
5. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
Neppelenbroek SIM; Geurts YM; Aleman BMP; Lugtenburg PJ; Rademakers SE; de Weijer RJ; Schippers MGA; Ta BDP; Plattel WJ; Zijlstra JM; van der Maazen RWM; Nijziel MR; Ong F; Schimmel EC; Posthuma EFM; Kersten MJ; Böhmer LH; Muller K; Koene HR; Te Boome LCJ; Bilgin YM; de Jongh E; Janus CPM; van Leeuwen FE; Schaapveld M
J Clin Oncol; 2024 Feb; ():JCO2301386. PubMed ID: 38359378
[TBL] [Abstract][Full Text] [Related]
7. Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study.
Zheng G; Sundquist J; Sundquist K; Ji J
BMC Cancer; 2021 Nov; 21(1):1210. PubMed ID: 34772394
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database.
Slattery ML; Kerber RA
JAMA; 1993 Oct; 270(13):1563-8. PubMed ID: 8371466
[TBL] [Abstract][Full Text] [Related]
9. Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma.
Veit-Rubin N; Rapiti E; Usel M; Benhamou S; Vinh-Hung V; Vlastos G; Bouchardy C
Oncologist; 2012; 17(6):783-91. PubMed ID: 22588325
[TBL] [Abstract][Full Text] [Related]
10. Population-based relative risks for specific family history constellations of breast cancer.
Albright FS; Kohlmann W; Neumayer L; Buys SS; Matsen CB; Kaphingst KA; Cannon-Albright LA
Cancer Causes Control; 2019 Jun; 30(6):581-590. PubMed ID: 31030355
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.
Milano MT; Li H; Gail MH; Constine LS; Travis LB
J Clin Oncol; 2010 Dec; 28(34):5088-96. PubMed ID: 20975072
[TBL] [Abstract][Full Text] [Related]
12. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
Elkin EB; Klem ML; Gonzales AM; Ishill NM; Hodgson D; Ng AK; Marks LB; Weidhaas J; Freedman GM; Miller RC; Constine LS; Myrehaug S; Yahalom J
J Clin Oncol; 2011 Jun; 29(18):2466-73. PubMed ID: 21576642
[TBL] [Abstract][Full Text] [Related]
14. Lobular breast cancer: excess familiality observed in the Utah Population Database.
Allen-Brady K; Camp NJ; Ward JH; Cannon-Albright LA
Int J Cancer; 2005 Nov; 117(4):655-61. PubMed ID: 15929077
[TBL] [Abstract][Full Text] [Related]
15. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†.
Di M; Panagiotou OA; Reagan JL; Niroula R; Olszewski AJ
Leuk Lymphoma; 2020 Dec; 61(14):3360-3368. PubMed ID: 32915087
[TBL] [Abstract][Full Text] [Related]
17. Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects.
McDuffie HH; Pahwa P; Karunanayake CP; Spinelli JJ; Dosman JA
BMC Cancer; 2009 Feb; 9():70. PubMed ID: 19250521
[TBL] [Abstract][Full Text] [Related]
18. Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics.
de Vries S; Schaapveld M; Kardaun JW; de Bruin KH; Krol AD; Lugtenburg PJ; Jacobse JN; Aleman BM; van Leeuwen FE
Clin Epidemiol; 2018; 10():1523-1531. PubMed ID: 30425583
[TBL] [Abstract][Full Text] [Related]
19. Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.
Horst KC; Fero KE; Hancock SL; Advani RH; Ikeda DM; Daniel B; Rosenberg SA; Donaldson SS; Hoppe RT
Am J Clin Oncol; 2016 Apr; 39(2):114-9. PubMed ID: 24390271
[TBL] [Abstract][Full Text] [Related]
20. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.
Chowdhry AK; Fung C; Chowdhry VK; Bergsma D; Dhakal S; Constine LS; Milano MT
Leuk Lymphoma; 2018 May; 59(5):1180-1187. PubMed ID: 28862484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
